Clinical Trials Browser

Phase 3 × Immunoproliferative Disorders × ponatinib × Clear all

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)